Reporter Sept 3 2021
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Sep. 2, 2021—Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.
Sep. 2, 2021—Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers.
Sep. 2, 2021—Middle Tennessee home builder Willow Branch Homes has donated one of their new homes to raffle off in support of Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Sep. 2, 2021—When a drug or combination of drugs causes different responses in different people, genetic variation is often at play. Pharmacogenomics, through discovery of genetic risk and use of clinical genotyping, aims to reduce trial-and-error approaches to drug prescribing.
Sep. 2, 2021—Cmdr. Lance LeClere, MD, former orthopaedic surgeon for the U.S. Navy Seals and current head team physician for the U.S. Naval Academy, is joining Vanderbilt Orthopaedics Lebanon at Vanderbilt Wilson County Hospital (VWCH) beginning Sept. 7.
Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
Sep. 1, 2021—A new institutional initiative will offer a secure and easy way for physicians at Vanderbilt University Medical Center to ask for help interpreting genetic test results for their patients.